NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,088 filers reported holding NOVARTIS A G in Q3 2019. The put-call ratio across all filers is 0.92 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $509,300 | -96.1% | 5,000 | -96.4% | 0.00% | -97.6% |
| Q1 2023 | $12,916,800 | +162.3% | 140,400 | +116.7% | 0.04% | +105.0% |
| Q3 2022 | $4,925,000 | -46.8% | 64,800 | -35.7% | 0.02% | -4.8% |
| Q2 2019 | $9,252,000 | +53.8% | 100,800 | +60.5% | 0.02% | -16.0% |
| Q1 2019 | $6,014,000 | -14.1% | 62,800 | -29.1% | 0.02% | +25.0% |
| Q3 2016 | $7,001,000 | -6.3% | 88,597 | -2.9% | 0.02% | -16.7% |
| Q2 2016 | $7,468,000 | -95.1% | 91,240 | -94.5% | 0.02% | -94.1% |
| Q4 2014 | $152,832,000 | -19.8% | 1,650,000 | -18.5% | 0.41% | -20.9% |
| Q3 2014 | $190,644,000 | +28.1% | 2,025,129 | +22.7% | 0.52% | +1131.0% |
| Q2 2014 | $148,881,000 | -14.4% | 1,650,200 | -19.8% | 0.04% | -20.8% |
| Q1 2014 | $173,899,000 | +9028.6% | 2,057,731 | +8186.9% | 0.05% | +381.8% |
| Q3 2013 | $1,905,000 | -36.7% | 24,831 | -41.5% | 0.01% | -65.6% |
| Q1 2013 | $3,009,000 | +445.1% | 42,412 | +384.3% | 0.03% | +433.3% |
| Q4 2012 | $552,000 | – | 8,757 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |